Persistent Asset Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-23
Closed -$1.57K 272
2025
Q2
$1.57K Hold
23
﹤0.01% 178
2025
Q1
$70.2K Buy
+23
New +$19.1K 0.06% 123

Other funds holding LLY

Persistent Asset Partners's LLY Position: Q2 2026 in Review

Persistent Asset Partners reduced its Eli Lilly (LLY) stake by 97% in Q2 2026, selling an estimated $1.89M and leaving 56 shares worth $67.2K. The position accounts for 0.02% of the portfolio, ranked #380.

Persistent Asset Partners first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.71M in Q1 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Persistent Asset Partners held 56 shares of Eli Lilly worth $67.2K as of Q2 2026.
  • Persistent Asset Partners sold 1,850 Eli Lilly shares in Q2 2026, an estimated $1.89M.
  • Eli Lilly made up 0.02% of Persistent Asset Partners's portfolio in Q2 2026, its #380 holding.
  • Persistent Asset Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Persistent Asset Partners's Eli Lilly position peaked at $3.71M in Q1 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.